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Abstract
Iron is an essential component of the erythrocyte protein hemoglobin and is crucial to oxygen 
transport in vertebrates. In the steady state, erythrocyte production is in equilibrium with 
erythrocyte removal1. In various pathophysiological conditions, however, erythrocyte life span is 
severely compromised, which threatens the organism with anemia and iron toxicity2,3. Here we 
identify an on-demand mechanism that clears erythrocytes and recycles iron. We show that 
Ly-6Chigh monocytes ingest stressed and senescent erythrocytes, accumulate in the liver via 
coordinated chemotactic cues, and differentiate to ferroportin 1 (FPN1)-expressing macrophages 
that can deliver iron to hepatocytes. Monocyte-derived FPN1+ Tim-4neg macrophages are 
transient, reside alongside embryonically-derived Tim-4high Kupffer cells, and depend on Csf1 and 
Nrf2. The spleen likewise recruits iron-loaded Ly-6Chigh monocytes, but these do not differentiate 
into iron-recycling macrophages due to the suppressive action of Csf2. Inhibiting monocyte 
recruitment to the liver leads to kidney and liver damage. These observations identify the liver as 
the primary organ supporting rapid erythrocyte removal and iron recycling and uncover a 
mechanism by which the body adapts to fluctuations in erythrocyte integrity.
The physiological 120 day lifespan of human erythrocytes (i.e., red blood cells, RBC)4,5 is 
shortened in various pathologies6–10. Red blood cell production requires a sufficient supply 
of iron: when iron stores are low, erythrocytes cannot be produced efficiently, causing 
anemia and tissue hypoxia. Because iron is poorly acquired through diet, most of the daily 
amount needed for erythropoiesis is recycled by the reticuloendothelial system in the spleen 
and liver in a process that depends on the transmembrane iron export protein ferroportin-1 
(FPN1)1,11,12. Disease-borne erythrocyte damage threatens the organism in several ways: (i) 
damaged erythrocytes release hemoglobin and heme, which can cause acute kidney injury; 
(ii) erythrocyte loss leads to anemia; and (iii) the heightened need for erythrophagocytosis 
may overwhelm physiologic erythrocyte-clearing capacities, thereby liberating vast 
quantities of iron, which, although essential to life, is toxic in its non-transferrin-bound 
form1. We therefore hypothesized that vertebrate animals have evolved mechanisms that can 
adapt to fluctuations in erythrocyte integrity.
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Erythrocytes and leukocytes can be identified as Ter119+ CD45− and Ter119− CD45+ cells, 
respectively (Supplementary Fig. 1a). Labeling erythrocytes with a membrane-integrating 
dye (pkh26) ex vivo allowed for in vivo detection and tracking (Fig. 1a). Whereas most 
“young” erythrocytes circulated in host blood for at least 16 h, aged and stressed 
erythrocytes13,14) quickly disappeared (Supplementary Fig. 1b). Stressed erythrocytes co-
localized with leukocytes predominantly in the liver (Fig. 1b), but also the spleen, bone 
marrow, blood, and lung. Although splenectomized mice had higher percentages of delivered 
erythrocytes in the circulation compared to non-splenectomized controls, near-complete 
hepatectomy (95%) resulted in pronounced erythrocyte persistence in the circulation, while 
combined splenectomy and near-complete hepatectomy had the greatest effect on the 
persistence of damaged RBC in the blood (Fig. 1c, d and Supplementary Fig. 2a).
In the steady state, the liver contains abundant F4/80high CD11bint Kupffer cells (KC) and 
relatively few CD11bhigh cells (Fig. 1e). Stressed erythrocyte challenge led to dramatic 
leukocyte fluctuations in the liver. At 3 h, monocyte numbers peaked (Figure 1f). At 16 h, a 
population of CD11bhigh F4/80high macrophages (henceforth called transient macrophages 
[tMΦ]) appeared (Fig. 1e, f), but F4/80high CD11bint KC diminished. At 72–168 h the 
populations returned to near-basal levels (Fig. 1e, f). The spleen, which contains F4/80high 
CD11bint red pulp macrophages (RPM) and monocytes, accumulated monocytes, but hardly 
any tMΦ, after stressed erythrocyte challenge (Fig. 1e, f). The phenomenon was specific to 
hemoglobin-containing erythrocytes as injecting hemoglobin-depleted “ghosts” did not 
induce the appearance of tMΦ (Fig. 1e).
We used two independent approaches to track sRBC uptake by leukocytes. First, flow 
cytometry and histology detected pkh26 fluorescence on gated and sorted leukocyte 
populations, respectively, as a surrogate for sRBC ingestion (Supplementary Figs. 2b–d and 
3). In the blood, Ly-6Chigh monocyte ingestion of sRBC peaked 1 h after challenge and 
sRBC-laden monocytes (Supplementary Fig. 4a) subsequently accumulated in the liver and 
spleen (Supplementary Fig. 4b, c). At 16 h, tMΦ in the liver contained the largest proportion 
of stressed erythrocytes (Fig. 1g and Supplementary Fig. 4b, c). No tMΦ appeared in the 
spleen, bone marrow, kidney, or lung (Supplementary Fig. 4d). Immunofluorescence 
substantiated these observations (Fig. 1h and Supplementary Fig. 2b, c). Second, we 
measured iron content in sorted leukocytes by atomic absorption spectroscopy, and 
confirmed that tMΦ in the liver contained the bulk of the iron (Fig. 1i) because of abundant 
sRBC ingestion, likely via scavenger receptors such as SR-A and CD36 (Supplementary Fig. 
5a–b)15. The spleen was dispensable to the appearance of tMΦ in the liver (Supplementary 
Fig. 5c), while lethal irradiation, which depleted monocytes without affecting KC or RPM at 
10 d, impaired erythrocyte clearance (Supplementary Fig. 5d–f).
Shortly after stressed erythrocyte challenge, we detected erythrophagocytosing macrophages 
by scanning electron microscopy (Fig. 1j) and observed a punctate pattern of iron stores that 
was consistent with confinement in macrophages (Supplementary Fig. 6a). By 1 week, 
however, iron was stored in hepatocytes, giving rise to a diffuse parenchymal accumulation 
pattern. Quantifying iron distribution showed the greatest increase in the liver, as well as 
enhanced hepatocyte-derived hepcidin (Supplementary Fig. 6b)1,4,16. Using a model of 
hemolytic anemia involving phenylhydrazine (PHZ) delivery17,18, anemia of inflammation 
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induced by heat-inactivated Brucella abortus19,20, and a model of sickle cell anemia21, we 
likewise detected tMΦ accumulation in the liver, but not spleen (Supplementary Fig. 7). In 
humans, erythrocyte damage resulted in erythrocyte accumulation in circulating classical 
monocytes along with higher intracellular and serum iron levels (Supplementary Fig. 8).
Macrophage-ingested iron is either stored in the cytoplasm or is exported via FPN111. The 
spleen and liver expressed Ferritin and FPN1 in the steady state (Supplementary Fig. 9a–c), 
as expected17,18. Among the leukocytes, KC and RPM expressed FPN1 on their surfaces 
(Fig. 2a) for iron transport (Supplementary Fig. 9d). However, transfusing stressed iron-
containing erythrocytes amplified FPN1 in the liver, but not the spleen (Fig. 2a and 
Supplementary Fig. 9a–c), and intensified FPN1 surface expression on tMΦ specifically in 
the liver (Fig. 2a). The abundant appearance of tMΦ required intact stressed erythrocytes 
(Supplementary Fig. 9e) and was exacerbated in response to competitive inhibition of the 
heme-cleaving enzyme heme-oxygenase (Hmox) 1 by tin-protoporphyrin IX (SnPP-IX) 
(Supplementary Fig. 9f). These results suggest that the liver is uniquely mechanistically 
equipped to respond to increased demand for erythrophagocytosis.
Given the phenotypic similarities between monocytes and tMΦ, we tested whether 
Ly-6Chigh monocytes give rise to FPN1+ tMΦ in the liver. We adoptively transferred GFP+ 
Ly-6Chigh and Ly-6Clow monocytes to animals receiving stressed erythrocytes. Immediately 
after transfer, both monocyte subsets circulated in the blood, but neither produced FPN1 
(Fig. 2b). 16 h later, Ly-6Chigh monocytes with augmented F4/80 appeared in the liver, thus 
resembling tMΦ (Fig. 2b). By 72 h, these Ly-6Chigh monocyte-derived tMΦ further 
differentiated to resemble KC; they still contained erythrocytes (or their remnants), and they 
still expressed FPN1 and classical macrophage signature proteins,22 MerTK and CD64, on 
their surfaces (Fig. 2b). In contrast, Ly-6Clow monocytes infiltrated the liver in lower 
numbers, did not differentiate to tMΦ, and remained FPN1−, MerTK−, and CD64− (Fig. 2b 
and Supplementary Fig. 9g). Moreover, monocyte-to-FPN1+ macrophage differentiation was 
specific to the liver, and only a few of the transferred cells from either subset accumulated in 
the spleen (Fig. 2b). We observed a similar phenomenon by transfering GFP+ Ly-6Chigh 
monocytes to the chronic sickle-cell disease model (Supplemetary Fig. 10a–b).
To test whether Ly-6Chigh monocytes can support long-term KC renewal or whether KC 
ultimately remain tissue-derived, we joined C57BL/6 and GFP+ mice by parabiosis 
(Supplementary Fig. 10c–d)23. In the absence of erythrocyte delivery, Ly-6Chigh blood 
monocyte chimerism rose to ~25% in the first 2 weeks and remained unchanged for >100 
days, while KC chimerism remained low at <2% for the duration of the experiment (Fig. 2c). 
Erythrocyte delivery 2 weeks after parabiosis began had no effect on blood monocyte 
chimerism, but magnified chimerism among KC for >28 days (Fig. 2c). In contrast, RPM 
chimerism in the spleen did not respond to erythrocyte challenge. The data show that a high 
demand for erythrophagocytosis mobilizes erythrocyte-ingesting Ly-6Chigh monocytes to the 
liver where they first differentiate to iron-recycling tMΦ and then to iron-recycling Kupffer-
like cells. When demand declines, monocyte-derived KC-like cells disappear, and the 
remaining KC replenish independently of monocytes or other circulating progenitors.
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To dig deeper into how monocyte and tissue-derived macrophages differ, we first sorted 
erythrocyte+ and erythrocyte− liver KC and tMΦ 16 h after erythrocyte challenge. We then 
profiled gene expression by RT-PCR (Fig. 2d) and flow cytometry (Supplementary Fig. 10e), 
detecting numerous differences, including in SPI-C expression17,18. Next, we performed 
formal lineage tracing experiments because increased KC chimerism after erythrocyte 
challenge (Fig. 2c), along with tMΦ’s shift to the KC gate, indicated that, for a limited time 
after challenge, KC are a mixed population comprising tissue and blood-derived cells. We 
used Cx3cr1-CreERT2 females mated with ROSA26-tdTomatofl/fl (R26-tdT) males24,25, 
which, in the Cx3cr1-CreERT2 R26-tdT pups, gave rise to tdT+ KC and tdT− monocytes 
(Fig. 2e). On day P70, we transplanted GFP+ bone marrow to generate GFP+ monocytes in 
the grown pups (Fig. 2e and Supplementary Fig. 11a). On day P91, we challenged the mice 
with stressed erythrocytes and, 7 days later, detected (embryonic, eKC) tdT+ GFP− and 
(monocyte-derived, mKC) tdT− GFP+ macrophages inside the KC gate. We then sorted these 
cells for microarray analysis (Fig. 2e). Our data showed numerous differences between the 
cells (Fig. 2f and Supplementary Fig. 11b), although iron metabolism mediators were 
comparable (Supplementary Fig. 11b, c). Among the differentially-expressed genes, Timd4, 
which produces the surface Tim-4 protein, was highly expressed in embryonic but not 
monocyte-derived KC (Fig. 2f), which we confirmed by flow cytometry (Fig. 2g). These 
data show that as tMΦ temporarily shift to the KC gate, they nevertheless differ from their 
embryonically derived counterparts.
The growth factors colony stimulating factor (Csf)-1 and Csf2 instruct myeloid cell fate 
decisions26,27. Following erythrocyte challenge, the liver and spleen augmented Csf1 (Fig. 
3a), the spleen but not liver augmented Csf2 expression (Fig. 3b), the lung augmented 
neither (Supplementary Fig. 12a), and the bone marrow augmented Csf2 (Supplementary 
Fig. 12b). Consequently, the liver had a high Csf1-to-Csf2 ratio whereas the spleen and bone 
marrow had a low Csf1-to-Csf2 ratio (Fig. 3c and Supplementary Fig. 12b) after stressed 
erythrocyte injection. To evaluate whether the growth factors cultivate the selective 
appearance of iron recycling macrophages, we first performed in vitro experiments. 
Ly-6Chigh monocytes (Fig. 3d) – and their human counterparts, CD14high CD16− monocytes 
(Fig. 3e) – cultured in a Csf1-rich environment amplified FPN1 in response to sRBC, while 
culture with Csf2 suppressed it (Fig. 3f). This antagonism was specific to monocytes, as 
cultured RPM retained FPN1 in the presence of Csf2 (Supplementary Fig. 12c). KC were 
the dominant source of Csf1 in vivo (Supplementary Fig. 12d) and Csf1-driven FPN1 
augmentation was specific to Ly-6Chigh when compared to Ly-6Clow monocytes 
(Supplementary Fig. 12e).
Nuclear factor, erythroid derived 2, like 2 (Nrf2) recognizes heme groups and facilitates 
FPN1 transcription28,29. In the absence of Nrf2, Csf1 failed to stimulate FPN1 production on 
Ly-6Chigh monocytes, which indicates that Csf1-dependent FPN1 enhancement requires 
Nrf2 (Fig. 3g). To confirm this in vivo, we delivered erythrocytes into either wild type mice 
receiving a Csf1 inhibitor or to Nrf2−/− mice. In both cases, FPN1+ tMΦ failed to arise in the 
liver despite the appearance of F4/80high and CD11bhigh cells (Fig. 3h). FPN1 expression on 
Kupffer cells likewise required Nrf2 but, unlike tMΦ, remained unaffected by Csf1 
blockade. To determine whether Csf2 suppressed the appearance of tMΦ in vivo, we also 
delivered erythrocytes into Csf2−/− mice. In the absence of Csf2, FPN1+ tMΦ appeared in 
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the spleen, concomitant with augmented iron metabolism mediators (Supplementary Fig. 
13). These data show that Nrf2 and Csf1 guide the production and maintenance of iron 
recycling macrophages in the liver, while Csf2 antagonizes iron recycling in the spleen 
under stress.
Because the liver selectively accumulated monocyte-derived tMΦ, we surmised that 
chemokines were guiding monocytes to this organ. The chemokines Ccl2 and Ccl3 (Fig. 4a) 
strongly responded to erythrocyte delivery in the liver but not the spleen, while expression of 
Ccl21 was curtailed in the spleen but not the liver (Supplementary Fig. 14). Differences 
among other chemokines were less pronounced (Supplementary Fig. 14a). Injecting Ccr2 
and Ccr5 antagonists in conjunction with stressed erythrocyte delivery reduced Ly-6Chigh 
monocyte and tMΦ populations in the liver but not the spleen or blood while increasing 
monocytes in the bone marrow (Fig. 4b), indicating impaired monocyte mobilization and 
recruitment. Accordingly, the antagonists boosted the number of circulating stressed 
erythrocytes in the blood, signaling impaired clearance (Fig. 4c).
Using this method, we discovered that interfering with on-demand monocyte recruitment 
increased enanched labile plasma iron (eLPI) (Fig. 4d), suggesting that impaired clearance 
of stressed erythrocytes by monocyte-derived tMΦ leads to the build-up in the circulation of 
tissue-damaging iron, heme, and hemoglobin. In support of this, we detected heightened 
production of haptoglobin and hemopexin in the liver (Fig. 4e) and higher levels of alanine 
aminotransferase (ALT), aspartate aminotransferase (AST), amylase, and blood urea 
nitrogen (BUN) (Fig. 4f). The number of tMΦ in the liver inversely correlated with eLPI, 
AST, and BUN (Supplementary Fig. 15). Moreover, blocking tMΦ accumulation in the liver 
led to increased iron deposition and nephron damage in the kidney following sRBC 
challenge (Fig. 4g and Supplementary Fig. 16a). We observed similar damage after Hmox1 
blocking 30, PHZ-induced hemolysis, and in sickle cell disease (Supplementary Fig. 16b). 
Finally, the clinical manifestations of inadequately cleared stressed erythrocytes by FPN1+ 
tMΦ were phenocopied in mice whose monocyte-derived macrophages lacked FPN1 
(Supplementary Fig. 17a–b)31, and were ameliorated in a rescue experiment using LysM-
specific FPN1-deficient mice (Supplementary Fig. 17c). These findings indicate that 
Ly-6Chigh monocyte hepatic recruitment and differentiation to iron-recycling macrophages 
preserves organismal homeostasis during fluctuations of erythrocyte integrity.
In sum, we show that Ly-6Chigh monocytes and their progeny propagate on-demand high-
capacity erythrophagocytosis and iron recycling. This liver-specific phenomenon is transient, 
dynamic, requires cell-intrinsic and environmental triggers, and controls iron homeostasis 
during erythrocyte damage (Supplementary Fig. 18). Understanding and eventually 
harnessing this mechanism may help to treat persons with abnormally heightened 
erythrocyte elimination due to sepsis, various forms of inflammation, frequent blood 
transfusions, and inborn and acquired defects in erythrocyte stability.
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Online Methods
Animals
C57BL/6J (wild type, WT), B6.SJL-PtprcaPepcb/BoyJ (CD45.1+), C57BL/6-Tg(UBC-
GFP)30Scha/J (GFP+), B6.129X1-Nfe2l2tm1Ywk/J (Nrf2−/−), B6.Cg-Msr1tm1Csk/J 
(Msr1−/−), B6.129S1-Cd36tm1Mfe/J (CD36−/−), B6.129-Hbatm1(HBA)Tow/
Hbbtm2(HBG1,HBB*)Tow (sickle cell disease, SCD) and B6.129-Hbatm1(HBA)Tow/
Hbbtm3(HBG1,HBB*)Tow (non-sickling transgenic control, tgCtrl.) mice were purchased from 
The Jackson Laboratory (Bar Harbor, ME, USA). GM-CSF-deficient mice (Csf2−/−) on a 
C57BL/6J background were bred in-house. B6.129S6-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J 
(ROSA26-tdTomatofl/fl or R26-tdT) and B6.129P2(Cg)-B6.129P2(C)-
Cx3cr1tm2.1(cre/ERT2)Jung/J (Cx3cr1-CreERT2) 24,25 were kindly provided by Prof. Dr. M. 
Prinz. Mice carrying the myeloid-specific knockout of the FPN1 gene (LysMCre/+ 
Slc40a1fl/fl) were kindly provided by Dr. F. Wang, back-crossed on a C57BL/6 background 
and bred in house. Unless otherwise indicated age- and sex-matched animals were used at 8 
– 12 weeks of age. Where appropriate, animals were randomly assigned to interventions. All 
protocols were approved by the Animal Review Committee at Massachusetts General 
Hospital (Protocol No. 2011N000035 and 2015N000044) and by the Federal Ministry of 
Science, Research and Economy in Austria (Project No. BMWFW-66.011/0115-WF/V/3b/
2014).
Erythrocyte preparation and pkh26 labeling
RBC preparation: Isolating, storing, and aging of red blood cells (RBC) from the blood of 
C57BL/6J WT mice was performed as described previously13. In detail, whole blood 
collected from C57BL/6J WT mice was pooled, centrifuged at 400 g for 10 min and the 
buffy coat was removed. In a second step RBC were diluted in PBS and further 
leukoreduced using a Neonatal High-Efficiency Leukocyte Reduction Filter (Purecell Neo, 
Pall Corporation). One part of RBC was placed in Eppendorf tubes and stored in the dark at 
4 °C for 14 d (aged, aRBC) and another part was heated for 20 min at 48 °C while 
continuously shaking, generating stressed erythrocytes (stressed, sRBC). Naïve young 
erythrocytes (yRBC) were stored in the dark at 4 °C and delivered within 1 h of isolation. 
Pkh26 labeling: 1 × 1010 RBC were resuspended in 1 ml diluent C, mixed with 1 ml diluent 
C containing 4 μM PKH-26 (Sigma, St. Louis, MO, USA) and incubated for 5 min at RT in 
the dark before stopping the reaction by adding 10 ml PBS with 0.5% BSA and 2% FCS. 
After two washing steps with PBS, RBC were resuspended in PBS followed by a 
centrifugation step at 400 g for 15 min to reduce the volume to a final hemoglobin level 
ranging from 17.0 to 17.5 g/dl, as determined by HemaTrue (Heska, Loveland, CO, USA). 
The number of residual leukocytes was enumerated by HemaTrue and flow cytometry. 
Human RBC used for in vitro experiments were prepared exactly as described above for 
mouse RBC. Ghost preparation: RBC ghosts were obtained by hypotonic lysis of twice the 
volume of aged RBC as used for in vivo experiments (ie, for 100 μl of ghosts, 200 μl of aged 
RBCs were hemolyzed) with PBS to distilled water (1:15), followed by at least 5 washes 
with the same buffer and centrifugation at 30 g for 5 min until a white pellet was obtained. 
The pellet of RBC ghosts was resuspended in PBS and used for in vivo experiments.
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Animal models and in vivo interventions
Hepatectomy and splenectomy: Lobectomy of liver tissue was performed after blood vessel 
ligation with 7-0 Ethilon suture. Removal of the left, median and caudate lobe (lobes 1–3) 
represented 70% liver resection. Removal of the left, median and right lateral lobe (lobes 2–
5) represented 95% liver resection. Removal of the small caudate lobe (lobe 1) served as 
sham control (see Supplementary Fig. 2a). Spleens were removed with the use of 
electrocauterization. Delivery of RBC: RBC were isolated and adjusted to 17.5 g/dl 
hemoglobin as described above. 400 μl were injected i.v. per mouse. This amount of RBC 
delivery in mice corresponds to transfusion of two units of packed RBC in humans. Ki20227 
injection: In some experiments the RBC transfer was accompanied by s.c. injection of the c-
fms tyrosine kinase inhibitor Ki20227 at 50 mg/kg bodyweight (Tocris Biosciences, Bristol, 
UK). DAPTA and RS504393 injection: In some experiments the RBC transfer was 
accompanied by i.p injection of the Ccr2 antagonist RS504393 at 1 mg/kg bodyweight 
dissolved in DMSO (Tocris Biosciences, Bristol, UK) and the Ccr5 antagonist DAPTA at 2 
mg/kg bodyweight (Tocris Biosciences, Bristol, UK) dissolved in sterile water. Both 
antagonists where administered again 6 h after sRBC transfer. SnPP-IX injection: In some 
experiments, the RBC transfer was accompanied by i.p injection of the heme-oxygenase 
(Hmox) 1 inhibitor tin-protoporphyrin IX (SnPP-IX) at 0.5 mg/kg bodyweight (Cayman 
Chemical, Ann Arbor, MI, USA). SnPP-IX was dissolved in 0.2 M NaOH and the pH was 
adjusted to 7.40 with 1 M HCl. SnPP-IX was administered every 8 h starting 30 min before 
sRBC transfer. Irradiation: In some experiments mice were lethally radiated (10 Gy) but not 
reconstituted with donor bone marrow cells for 10 d. Adoptive transfer: Ly-6Chigh and 
Ly-6Clow monocytes were isolated by flow assisted cell sorting (FACS) from spleens or 
bone marrow of GFP+ mice and 1 × 106 cells/mouse were injected i.v. followed by an 
additional sRBC injection. Parabiosis: Mice were joined in parabiosis as previously 
described32. In brief, the opposing lateral sides of mice were shaved, skin incisions made 
from behind the ear to the tail and the skin was bluntly detached from the subcutaneous 
fascia over a width of about 1 cm. At the laterally-exposed areas of each parabiont a 1 cm 
long incision of the peritoneum was made and the corresponding edges were sutured 
together joining the two peritoneal cavities. Finally the parabionts were joined by suturing 
the corresponding scapulas and the skin with Ethylon 5-0 (Ethicon, Albuquerque, NM, 
USA). Both parabionts were injected in parallel with 400 μl sRBC or saline as control. 
Hemolytic anemia model involving PHZ: C57BL/6J WT mice were administered 2 mg/
mouse phenylhydrazine (PHZ; from Sigma-Aldrich, St. Louis, MO, USA) dissolved in 200 
μL PBS i.p. Three days after injection, peripheral blood was drawn from the cheek and 
measured for RBC content on VetScan hematology analyzer (Abaxis Veterinary Diagnostics, 
Union City, CA, USA). Liver was excised after vascular perfusion with 20 ml sterile PBS, 
minced, and strained through a 40 μm-nylon mesh (BD Bioscience, San Jose, CA, USA). 
The single cell suspension was then stained with antibodies for flow cytometric analysis. 
Brucella abortus-induced anemia model: To induce anemia, animals were injected i.p. with 1 
× 109 particles per mouse of a commercially heat-killed B. abortus preparation (strain 
1119-3; US Department of Agriculture, Animal and Plant Health Inspection Service, 
National Veterinary Services Laboratories, San Francisco, CA, USA). Control mice were 
injected i.p. with normal saline. During the experiments, mice were studied on days 0, 2, and 
9 after injection. Sickle cell anemia model: Unless otherwise indicated, sickle cell disease 
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mice and transgenic controls were studied in steady-state. Lineage Tracing Experiments: 
Radiation-free bone marrow chimeras. 2 – 3 month old WT mice were treated with low dose 
busulfan (Busilvex: purchased from Pierre Fabre, Freiburg, Germany; 10 mg/kg, i.p.) and 
transplanted with 50 – 70 × 106 bone marrow cells obtained from GFP+ mice 3 days later. 
Blood leukocyte chimerism (GFP positivity) was tested every week and reached typically 50 
– 90% among Ly-6Chigh monocytes. 3 weeks after bone marrow transplantation, mice were 
treated with sRBC or PBS and sacrificed 4 – 7 days later and chimerism of organ-resident 
myelocytes was checked with flow cytometry with co-staining for lineage and myeloid cell 
markers. tdTomato mice. Pregnant Cx3cr1-CreERT2 mice (mated with R26-tdT) were 
injected s.c. with tamoxifen (Sigma-Aldrich, 8 mg/animal in 400 μl corn oil) on days E13.5 
and 15.5 to induce tdTomato expression in embryonic monocytes/macrophages. Pups were 
derived by Cesarian cut on day E21 and placed with nursing FVB/N dams. The Cx3cr1-
CreERT2R26-tdT pups were distinguished from the genuine litter by coat color. At the age 
of 10 weeks (P70) mice were transplanted with GFP bone marrow after busulfan pre-
conditioning (see Radiation-free bone marrow chimeras) and challenged with sRBC or PBS 
as described above (P91). Chimerism and tdTomato expression among blood leukocytes and 
organ-resident myelocytes was determined by flow cytometry. FPN1-deficient rescue 
experiments: LysMCre/+ Slc40a1fl/fl mice were treated with busulfan and transplanted with 
either LysM+/+ Slc40a1fl/fl (WT) or LysMCre/+ Slc40a1fl/fl (FPN1−/−) bone marrow cells as 
described above for WT mice. 3 weeks after transplantation mice were infused with sRBC 
and sacrificed 16 h later. Serum and organ samples were collected and processed for liver 
and kidney function parameters and histology.
Murine Cells
Collection: Peripheral blood was collected by retroorbital bleeding with heparinized 
capillaries and, where appropriate, erythrocytes were lysed in RBC Lysis buffer (Biolegend, 
San Diego, CA, USA). Spleen and liver were excised after vascular perfusion with 20 ml 
sterile PBS. Organs were minced and strained through a 40 μm-nylon mesh (BD 
Biosciences, San Jose, CA, USA). To increase the yield of hepatic macrophages, minced 
liver tissue was digested in 450 U/ml collagenase I, 60 U/ml DNase I and 60 U/ml 
hyaluronidase (Sigma-Aldrich, St. Louis, MO, USA) in PBS for 20 min at 37 °C while 
shaking. Cells were counted in a Neubauer chamber. Sorting: Murine monocytes, 
macrophages, neutrophils, B cells and T cells from blood, spleen and liver homogenates 
were isolated by FACS with a FACS Aria II cell sorter. For adoptive transfer and culture 
experiments murine spleen homogenates were enriched for monocytes prior to flow assisted 
cell sorting. In brief, splenocytes were incubated with 1 μl anti-CD11b (clone M1/70, BD 
Bioscience, San Jose, CA, USA) or anti-CD115 Ab (clone AFS98, ebioscience, San Diego, 
CA, USA) per 1 x 108 cells in sterile 2% FBS, 0.5% BSA in PBS for 30 min on ice, 
followed by MACS bead incubation and positive selection with a Midi MACS separator and 
LS column (all from Miltenyi, Bergisch Gladbach, Germany) according to the 
manufacturer’s instruction. Kupffer cells sorting in lineage tracing experiments: To 
maximize the yield of Kupffer cells (KC), animals were perfused with Liberase™ (Roche, 
Mannheim, Germany) according to a published protocol33. The obtained single cell 
suspension was centrifuged at 30 g for 3 min to pellet hepatocytes, the supernatants 
centrifuged at 300 g for 5 min to pellet the non-parenchymal fraction. The pellets were 
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stained for Lineage (CD3, CD19, Ly-6G, NK1.1), CD45, CD11b and F4/80 markers. In case 
of marrow-transplanted WT mice, GFP+ and GFP− KC were sorted from PBS- and sRBC-
transfused mice. In case of Cx3cr1-CreERT2R26-tdT mice infused with sRBC, tdTomato+ 
GFP− (eKC) and tdTomato- GFP+ (mKC) Kupffer cells were sorted into cooled 0.5 ml 
Eppendorf tubes containing 350 μl RLT Buffer (Qiagen, Hilden, Germany) with addition of 
1:100 β-mercaptoethanol. The amount of the sorted eKC and mKC was 5 × 104 cells per 
tube, at least 3 such tubes were collected per animal and pooled in the course of RNA 
isolation.
Human Cells
Collection: 5 persons (1 female, 4 males) undergoing cardiac surgery with the necessity for 
extracorporal circulation in the form of cardiopulmonary bypass (CPB) involving the Cell 
Saver® autologous blood recovery system (Haemonetics Corporation, Braintree, MA, USA) 
were enrolled in an observational study approved by Partners Human Research Committee 
(Protocol No. 2013P002596/MGH). Written informed consent was obtained in accordance 
with the Declaration of Helsinki from these persons. Indications for cardiac surgery were 
aortic valve replacement (n = 3), aortic valve replacement and concurrent coronary artery 
bypass grafting (n = 1) and repair of an aneurysm of the aortic sinus (n = 1). A mean volume 
of 755 ml of cell saver including autologous RBC but no packed RBC were transfused in the 
course of surgeries which had a mean duration of 242 min and a mean CBP time of 105 min. 
Peripheral blood samples were taken prior to, 15 min after, and 4 h after extracorporal 
circulation. Sorting: Human monocytes were isolated by FACS with a FACS Aria II cell 
sorter (BD Biosciences). Human peripheral blood mononuclear cells (hPBMC) were 
enriched for monocytes prior to FACS. PBMC were isolated from heparinized whole blood 
by the use of Ficoll density gradient centrifugation. For further enrichment hPBMC were 
incubated with 2 μl anti-HLA-DR (clone L243, BD Biosciences) or 2 μl anti-CD14 (clone 
MP9, BD Biosciences) per 1 × 108 cells in sterile 2% FBS, 0.5% BSA in PBS for 30 min on 
ice, followed by MACS bead incubation and positive selection with a Midi MACS separator 
and LS column according to the manufacturer’s instruction.
Flow Cytometry
Cell suspensions were stained in PBS supplemented with sterile 2% FBS and 0.5% BSA. 
The following monoclonal antibodies were used for murine flow cytometric analysis: anti-
Ly-6C (clone AL-21, BD Biosciences, San Jose, CA, USA), anti-CD45.1 (clone A20, 
Biolegend, San Diego, CA, USA), anti-CD45.2 (clone 104, BD Biosciences), anti-CD3e 
(clone 145-2C11, ebioscience, San Diego, CA, USA), anti-CD90.2 (clone 53-2.1, BD 
Biosciences), anti-CD19 (clone 6D5, Biolegend), anti-B220 (clone RA3-6B2, BD 
Biosciences), anti-MHCII (clone AF6-120.1, BD Biosciences), anti-F4/80 (clone BM8, 
Biolegend), anti-CD49b (clone DX5, BD Biosciences), anti-NK1.1 (clone PK136, BD 
Biosciences), anti-Ly-6G (clone 1A8, BD Biosciences), anti-CD11b (clone M1/70, BD 
Biosciences), anti-CD11c (clone HL3, BD Biosciences), anti-Ter119 (clone Ter-119, BD 
Biosciences), anti-CD115 (clone AFS98, ebioscience), anti-mMer (MerTK, clone 108928, 
R&D), anti-mFcgammRI (clone 290322, R&D), anti-CD14 (Sa14-2, Biolegend), anti-CD36 
(HM36, Biolegend), anti-CD80 (16-10A1, Biolegend), anti-CD86 (GL-1, Biolegend), anti-
CD206 (C068C2, Biolegend), anti-CD209a (MMD3, Biolegend), anti-CD278 (7E.17G9), 
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anti-MARCO (MCA 1849 FT, Biorad), anti-Tim-4 (RMT 4-54, eBioscience). Monoclonal 
rat-anti-mouse Ferroportin-1 (FPN1; Amgen, clone 1E11) antibody34 was conjugated with a 
Pacific blue dye using the APEX™ Pacific Blue Antibody Labeling Kit (Life Technologies, 
Carlsbad, CA, USA) according to the manufacturer’s instructions and compared against an 
isotype control mIgG2a PacBlue (clone MOPC-173, Biolegend). Specifically, erythrocytes 
were defined as CD45− Ter119+. Monocytes were identified as CD45+, Lin− (Lin = CD3, 
CD90.2, CD19, B220, NK1.1, CD49b, Ly-6G), CD11b+, F4/80low, MHCIIlow, CD11clow, 
CD115+ cells, subdivided into Ly-6Chigh and Ly-6Clow populations. Neutrophils were 
identified as CD45+, Lin+, CD11b+, F4/80−, MHCIIlow, CD11clow, SSChigh, Ly-6Cint cells. 
Red pulp macrophages (RPM) were identified as CD45+, Lin−, CD11blow, F4/80high and KC 
as CD45+, Lin−, CD11bint, F4/80high cells. The following antibodies were used for human 
flow cytometric analyses: anti-CD11b (clone ICRF44, BD Biosciences), anti-HLA-DR 
(clone L243, BD Bioscience), anti-CD16 (clone 3G8, BD Biosciences), anti-CD14 (clone 
MP9, BD Biosciences), anti-CD56 (clone NCAM16.2, BD Biosciences), anti-CD235a 
(clone GA-R2, BD Biosciences). Cells were first gated using FSC/SSC characteristics, and 
doublets were excluded by comparing FSC-height and -area signals. Classical monocytes 
were identified as HLA-DR+, CD11b+, CD14high, CD16− and nonclassical monocytes as 
HLA-DR+, CD11b+, CD14dim, CD16+, CD56−. Data were acquired on an LSRII (BD 
Biosciences) and analyzed with FlowJo v8.8.6 (Tree Star, Inc., Ashland, USA).
Cell and molecular biology
Cell culture: Human and murine monocyte subsets were cultured at 0.7 × 106/500 μl in 
RPMI-1640 supplemented with 10% FBS, 2 mM L- glutamine, 100 U/ml penicillin, 100 
μg/ml streptomycin, in a 24 well plate (Falcon™; obtained from Fisher Scientific, Pittsburgh, 
PA, USA). Recombinant (r) Csf1/rCSF1 (50 ng/ml, Preprotech, Rocky Hill, NJ, USA), 
rCsf2/rCSF2 (100 ng/ml, Preprotech, Rocky Hill, NJ, USA) were added to the cell cultures 
for 72 h. 6 h before termination of the experiment a 10-fold excess of sRBC was added. In 
vitro RBC uptake: 50,000 murine FAC-sorted cells were seeded onto 24-well plates in 500 
μl RPMI-1640 supplemented with 10% autologous serum, L-glutamine and antibiotics. 
Subsequently, cells were stimulated with PBS or 500,000 pkh26-labeled naive yRBC or 
sRBC for 1 h. Cells were washed 2× in 1× RBC lysis buffer to remove surplus RBC, and 
incubated in RPMI-1640 for another 2 h. Thereafter, cells were washed twice with 1 ml of 
1× RBC lysis buffer for 10 min before antibody staining for flow cytometry. To test for a 
possible cell-cell transfer of pkh26, 50,000 FAC-sorted cells per population tested were 
seeded in mono-culture or co-culture in 24-well plates for up to 72 h. To identify individual 
populations after co-culture, KC were harvested from CD45.2+ GFP+ donors whereas tMΦ 
and monocytes were of the CD45.1+ genotype (and thus GFP−). To identify the cellular 
source of Ccl2, Ccl3 and Csf1, individual cell populations were FAC-sorted from liberase-
perfused livers of mice under steady state conditions (KC) or 16 h after elicitation of tMΦ 
and monocytes with sRBC. 250,000 cells were seeded onto 6-well plates in 1 ml 
RPMI-1640 supplemented with 10% FBS, L-glutamine and antibiotics. After additional 16 h 
of culture, supernatants were frozen to measure chemokine/growth factor concentrations by 
means of a specific ELISA strictly according to the manufacturer’s (R&D) protocol. 59Fe–
release assay: The iron release assay was performed with the use of 59Fe-citrate (Perkin 
Elmer, Llantrisant, UK). Sorted KC and RPM were seeded in 24 well plates, each well with 
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30,000 cells. The release assay was performed exactly as described previously2. In brief, 
seeded KC/RPM were washed three times with 1 ml of serum-free, HEPES-buffered DMEM 
(2 mM L-glutamine, 50 mg/ml ampicillin, 25 mM HEPES (Sigma-Aldrich), pH 7.4) and 
incubated in 2 ml of this solution. Thereafter 5 μM 59Fe-citrate was added to the samples 
and incubated for 2 h to allow iron loading. Cells were then washed with 500 μL of serum-
free, HEPES-buffered DMEM and incubated for 2 h. Following three washing cycles with 
500 μL of 0.9% NaCl plus 50 μM 58FeCl3, cells were lysed with 400 μl 0.1% SDS and 
quantified by a γ-Counter. Protein concentration was determined by BCA assay (BCA 
Protein Assay Kit; Pierce Thermo Scientific). Western blotting: Cytosolic protein was 
extracted from freshly isolated tissue and Western blotting was performed as previously 
described35. Anti-Ferritin antibody (2 μg/ml, Dako, Austria), rabbit anti-rat-Ferroportin-
antibody2, rabbit anti-mouse-Hmox1 antibody (ADI-SPA-895-D, Enzo Life Sciences, 
1:1000), rabbit anti-mouse/human-TfR1 (H68.4, Invitrogen, 1:1000) or anti-actin (2 μg/ml, 
Sigma, Germany) were used as described previously. NIH ImageJ was used to quantify 
Western blot bands densitometrically. ELISA: Cytosolic protein was isolated from liver and 
spleen by 10 consecutive freeze-thaw cycles performed in PBS in the presence of 1× Halt™ 
Protease inhibitor cocktail (Pierce Pierce Thermo Scientific, Grand Island, NY, USA). 
Homogenous extracts were centrifuged at 10,000 g for 10 min and supernatants used as 
input in specific ELISA kits (LifeSpan BioSciences, Seattle, WA, USA). RNA preparation 
from tissue, reverse transcription, and real-time PCR: Total RNA preparation from nitrogen-
frozen mouse tissue and cultured cells, reverse transcription, and real-time polymerase chain 
reaction (RT-PCR) were performed as previously described33. For total RNA preparation 
from 3 × 104 freshly sorted human and murine monocytes, cells were lysed in RLT buffer 
with 1% β-mercaptoethanol. RNA was isolated with the RNeasy Micro Kit (Qiagen, Venlo, 
Netherlands) followed by cDNA transcription.
Primer sets without probes used SYBR Green detection. They were designed by Primer3 
software or the NCBI Primer Blast. The following primers and probes were used:
Hamp (hepcidin): fw 5′-GGC AGA CAT TGC GAT ACC AAT-3′, rv 5′-TGC 
AAC AGA TAC CAC ACT GGG AA-3′, probe FAM-CCA ACT TCC CCA 
TCT GCA TCT TCT GC-BHQ1.
Slc40a1: fw 5′-CTA CCA TTA GAA GGA TTG ACC AGC T-3′, rv 5′-CAA 
ATG TCA TAA TCT GGC CGA-3′, probe FAM-CAA CAT CCT GGC CCC 
CAT GGC-BHQ1.
SLC40A1: fw 5′-TGA CCA GGG CGG GAG A -3′, rv 5′-GAG GTC AGG 
TAG TCG GCC AA-3′, probe FAM-CAC AAC CGC CAG AGA GGA TGC 
TGT G-BHQ1.
Ccl2: fw 5′-CTT CTG GGC CTG CTG TTC A-3′, rv 5′-CCA GCC TAC 
TCA TTG GGA TCA-3′, probe FAM-CTC AGC CAG ATG CAG TTA ACG 
CCC C-BHQ1.
Ccl3: fw 5′-AGC TGA CAC CCC GAC TGC′, rv 5′-GTC AAC GAT GAA 
TTG GCG TG-3′, probe FAM-TGC TGC TTC TCC TAC AGC CGG AAG 
AT-BHQ1.
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Ccl5: fw 5′-GGA GTA TTT CTA CAC CAG CAG CAA -3′, rv 5′-CAC ACA 
CTT GGC GGT TCC TT-3′, probe FAM-TGC AGT CGT GTT TGT C -
BHQ1
Slc11a2: fw 5′-GGA CTG TGG ACG CTC GGT AA -3′, rv 5′-AAT GTT 
GCC ACC GCT GGT -3′, probe: FAM-CAT CTC GAA AGT CCT GCT GAG 
CGA AGA-BHQ1
Tgf1: fw 5′-ACT GGA GTT GTA CGG CAG TGG -3′, rv 5′-TGC AGT 
GAG CGC TGG ATC GA -3′, probe: FAM-TGA ACC AAG GAG ACG GAA 
TAC AGG GCT-BHQ1
Il6: fw 5′-TGT TCT CTG GGA AAT CGT GGA -3′, rv 5′-AAG TGC ATC 
ATC GTT GTT CAT ACA-3′, probe: FAM-ATG AGA AAA GAG TTG TGC 
AAT GGC AAT TCT-BHQ1
Il10: fw 5′-CCA GAG CCA CAT GCT CCT AGA -3′, rv 5′-TGG TCC TTT 
GTT TGA AAG AAA GTC T -3′, probe: FAM-TGC GGA CTG CCT TCA 
GCC AGG-BHQ1
Tfrc: fw 5′-CGC TTT GGG TGC TGG TG -3′, rv 5′-GGG CAA GTT TCA 
ACA GAA GAC C -3′, probe: FAM-CCC ACA CTG GAC TTC GCC GCA-
BHQ1
Hmox1: fw 5′-CGA CAG CAT GCC CCA GGA TTT GTC -3′, rv 5′-GTG 
ATG GAG CGT CCA CAG C -3′, probe: FAM-TGG TGG CCT CCT TCA 
AGG-BHQ1
Il1b: fw 5′-ACC TGT CCT GTG TAA TGA AAG ACG -3′, rv 5′-TGG GTA 
TTG CTT GGG ATC CA -3′, probe: FAM-CAC ACC CAC CCT GCA GCT 
GGA GA-BHQ1
Csf1: fw 5′-CCC AGA TCC CTG AGT C-3′, rv 5′-GTC TCG ATG GCT 
CCT C-3′
Nfe2l2: fw 5′-AGT CCC AGC AGG ACA T- 3′, rv 5′-AGT CAA ACA CTT 
CTC GAC TT- 3′
NFE2L2: fw 5′-TTG TAG ATG ACA ATG AGT CAC-3′, rv 5′-GAC TGA 
GCC TGA TTA GTA GC-3′
Cx3cl1: fw 5′-TGC TGC TTC TCC TAC AGC CGG AAG AT-3′, rv 5′-TGC 
TGC TTC TCC TAC AGC CGG AAG AT-3′
Cxcl12: fw 5′-TGC TGC TTC TCC TAC AGC CGG AAG AT-3′, rv 5′-TGC 
TGC TTC TCC TAC AGC CGG AAG AT-3′
Ccl21: fw 5′-TGC TGC TTC TCC TAC AGC CGG AAG AT-3′, rv 5′-TGC 
TGC TTC TCC TAC AGC CGG AAG AT-3′
Cyp2e1: fw 5′-GAG GTG CTA CTG AAC CAC AAG- 3′, rv 5′-ACG GAG 
GAT ACT TAG GGA AAA CC-3′
Theurl et al. Page 13
Nat Med. Author manuscript; available in PMC 2017 January 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fas: fw 5′-AGG TGG TGA TAG CCG GTA TGT-3′, rv 5′-TGG GTA ATC 
CAT AGA GCC CAG-3′
Srebf1: fw 5′-CCG GGG AAC TTT TCC TTA AC-3′, rv 5′-TGG TTG TTG 
ATG AGC TGG AG-3′
Ppara: fw 5′-CTG TCA TCA CAG ACA CCC TCT C-3′, rv 5′-TAT TCG 
ACA CTC GAT GTT CAG G-3′
Cd163: fw 5′-CAT GTG GGT AGA TCG TGT GC -3′, rv 5′-TGT ATG CCC 
TTC CTG GAG TC -3′
Retnla: fw 5′-CAT GTG GGT AGA TCG TGT GC -3′, rv 5′-CAG TAG CAG 
TCA TCC CAG CA -3′
Chi3l3: fw 5′-CCA GCA GAA GCT CTC CAG AA -3′, rv 5′-GTA CAC 
AGG CAG GGG TCA AT -3′
Mrc1: fw 5′-ATG CCA AGT GGG AAA ATC TG -3′, rv 5′-TGT AGC AGT 
GGC CTG CAT AG -3′
Spic: fw 5′-CCA CTT GGT TTT CCT GAA CGT -3′, rv 5′-TTG CGG AAA 
TGT CAG CGA GTA -3′
Pu1: fw 5′-TGG AGA AGC TGA TGG CTT GG -3′, rv 5′-CCA GCA GGA 
ACT GGT ACA GG -3′
Irf4: fw 5′-AAT CCC CAT TGA GCC AAG CA -3′, rv 5′-CTC GTC GTG 
GTC AGC TCT TT -3′
Irf5: fw 5′-ACC TGT CCT GTG TAA TGA AAG ACG -3′, rv 5′-TGG AAG 
TCA CGG CTT TTG TTA AG -3′
Clec4f: fw 5′-TTT TGT GGT GGC TTC ACA GC -3′, rv 5′-TCC AGA GTT 
GTT GCT TCC CC -3′
Bach1: fw 5′-GTC TCG GCT CCG GTC G -3′, rv 5′-TCG TAG GCA AAT 
ACC GC ACT -3′
Melting curve analysis was performed with each run to test specificity in Sybr green assays. 
Agarose gel electrophoresis of PCR products was performed with first primer tests to ensure 
a single product. RT-PCR was performed on a Bio-Rad CFX96 light cycler. Ssofast Probes 
Supermix and Ssofast EvaGreen Supermix (Bio-Rad, Vienna, Austria) were used according 
to the manufacturer’s instructions. Relative quantities were calculated by Bio-Rad’s CFX 
Manager software based on a standard curve calculated from four serial 10-fold dilutions of 
the standard. A standard curve was pipetted on each individual plate.
Chemistry
Blood samples from anesthetized mice were collected. Whole blood was further processed 
by centrifugation at 10,000 rpm for 5 min for serum isolation, which was then tested using 
comprehensive metabolic panels (AST, ALT, BUN, Amylase) and an Abaxis Piccolo 
chemistry analyzer.
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Histology & Microscopy
Immunofluorescence: Cell specific uptake of pkh26-labeled RBC was visualized by 
immunofluorescence microscopy. Sorted WBC populations from liver, spleen, and blood 
were prepared to a cell suspension of 2.5 × 105 cells/ml. 200 μl of suspension per cuvette 
were centrifuged at 500 rpm for 3 min. After air drying cells were embedded in Vectashield 
Mounting Medium with DAPI H1200 (Vector Lab, Burlingame, CA) and analyzed using a 
Nikon 80i upright epifluorescence microscope with Hamamatsu Orca CCD camera and 
complete image analysis software (IP Lab). Transmission Electron Microscopy: Tissues 
were fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4 (Electron 
Microscopy Sciences, Hatfield, PA) overnight at 4 °C. The tissues were rinsed in buffer, 
post-fixed in 1% osmium tetroxide in cacodylate buffer for 1 h at RT, rinsed in buffer and 
dehydrated through a graded series of ethanol to 100%, followed by propylene oxide, 100%. 
They were then infiltrated with Epon resin (Ted Pella, Redding, CA) in a 1:1 solution of 
Epon:propylene oxide overnight on a rocker at RT. The following day they were placed in 
fresh Epon for several hours and then embedded in Epon overnight at 60 °C. Thin sections 
were cut on a Leica EM UC7 ultramicrotome, collected on formvar-coated grids, stained 
with uranyl acetate and lead citrate and examined in a JEOL JEM 1011 transmission 
electron microscope at 80 kV. Images were collected using an AMT digital imaging system 
(Advanced Microscopy Techniques, Danvers, MA).
Iron detection
Prussian blue staining: Liver tissue was embedded in Tissue-Tek O.C.T. compound (Sakura 
Finetek, Alphen aan den Rijn, Netherlands), frozen and sectioned into 6 μm slices. Kidney 
tissue was fixed overnight in 10% paraformaldehyde, and embedded in paraffin before 
sectioning. Iron staining Kit (Sigma, Saint Louise MO, USA) was used for Prussian blue 
staining according to manufacturer’s instructions. Tissues were stained by a histologist 
single-blinded to study design and treatment group. A Zeiss Axioscope 40 microscope with 
a 40× lens and an AxioCam MRc5 (Carl Zeiss AG, Oberkochen, Germany) was used. The 
slides were scanned by a digital scanner Nanozoomer 2.0RS (Hamamatsu, Japan). 
Representative fields were photodocumented using a pixellink® system. Serum and Tissue 
Iron measurement: Serum iron concentrations were measured with a commercially available 
colorimetric iron quantification kit (QuantiChrom™ Iron Assay Kit, BioAssay Systems, 
Hayward, CA, USA). Tissue iron was measured with a colorimetric method as previously 
described36 adapted to a 96-well format as detailed elsewhere37. Briefly, 20–30 mg tissues 
were homogenized in cytoplasmic lysis puffer (25 mM Tris-HCl, pH 7.4, 40 mM KCl, 1% 
Triton X-100) supplemented with 1 μg/ml aprotinin and 1 μg/ml leupeptin (all from Sigma, 
St Louis, MO, USA) and centrifuged at 20,000 g for 15 min. 100 μl of the obtained 
supernatant was supplemented with 50 μl acid hydrolysate solution (7 ml HCl 37%, 3 g 
TCA diluted with aqua destillata (a.d.) to 10 ml). The samples were incubated at 65 °C with 
vertical mixing (100 rpm) for 24 h. Samples were then centrifuged at 3,000 g for 15 min. 60 
μl of the obtained supernatant from each sample were transfered into a 96 well plate in 
doublets and 160 μl of a colorimetric solution (1:1 mixture of 15.6 g sodium acetate diluted 
to 45 mL with a.d., and 17 mg of bathophenanthroline disulfonic acid and 22 mg L-ascorbic 
acid diluted to 5 mL with a.d.) was added to each sample and a Fe2+ standard curve was 
prepared via serial dilution of a purchased 10 mg/dL FeSO4 stock (BioAssay Systems®, 
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Hayward, CA, USA). Probes were incubated for 15 min at RT to allow colorimetric reaction, 
following photometric measurement of optical density at 539 nm. The calculated iron 
quantity was normalized against the wet tissue weight for each sample. Intracellular iron 
determination by graphite furnace atomic absorption spectrometry in sorted cells: A 
Detection was carried out in a single-blinded manner by utilizing a PerkinElmer Analyst 800 
equipped with a transversely heated graphite atomizer (THGA). A Zeeman-effect 
background correction was realized by a 0.8 T magnetic field, oriented longitudinally with 
respect to the optical path. A PerkinElmer Lumina single element iron hollow cathode lamp 
was driven at a constant current of 30 mA after proper equilibration (i.e. ≥ 20 min). For the 
absorption measurements, the 248.3 nm line (spectral bandwidth 0.7 nm) was chosen. The 
samples were suspended in 200 μl of a 0.1 % (v/v) solution of nitric acid (Rotipuran Supra, 
69 %, Carl Roth GmbH, Karlsruhe, Germany) in high-purity water (Milli-Q, Merck-
Millipore, Darmstadt, Germany) by extended periods (i.e. ≥ 30 min) of vortexing and 
ultrasonication at 30–40 kHz. After an initial estimation of the samples’ iron quantity, a five-
point linear calibration was established in the range between 0 (i.e. < 0.004 μM) and 0.106 
μM. The calibration standards were prepared by diluting a 0.1 M standard stock solution of 
(NH4)2Fe(SO4)2 (Merck-Millipore, Darmstadt, Germany) with a 0.1 % (v/v) aqueous 
solution of nitric acid (vide supra). The absence of detectable iron (i.e. < 0.004 μM) in the 
dilution agent as well as in the sample cups and the glassware was verified throughout the 
analyses. A linear fit of the 15 data points (k = 0.978, d = 0.006 μM) yielded a coefficient of 
determination of 0.992. Samples with iron concentrations exceeding the calibration range 
(i.e. ≥ 0.106 μM) were diluted appropriately. The blank solution, the calibration standards 
and the samples were supplied to the atomizer in randomized fashion as triplicates, utilizing 
a PerkinElmer AS-800 autosampler with an injection volume of 20 μl. The solvent was 
evaporated by a slow temperature gradient to 130 °C, ashing took place at a maximum 
temperature of 1000 °C and the atomization profile was read at 2000 °C. The graphite tube, 
being protected against oxidation by high-purity argon (99.999 %, Messer Austria GmbH, 
Gumpoldskirchen, Austria) was cleaned-out after each analysis at 2450 °C. The integrity of 
each analysis was verified by a visual inspection of the respective time-dependent 
atomization profile. Enhanced labile plasma iron detection. eLPI (enhanced labile plasma 
iron) was assessed by the FeROS eLPI kits, a fluorescence-based assay intended for in vitro 
semiquantitative detection of both over and cryptic redox active forms of NTBI (Aferrix Tel 
Aviv, Israel). eLPI > 0.3 units indicated the potential for iron-mediated production of 
reactive oxygen species in the sample.
Microarray measurement and microarray data processing
Total RNA was isolated from the eKC and mKC sorted from Cx3cr1-CreERT2R26-tdT mice 
with the RNeasy Micro Kit (Qiagen, Hilden, Germany) according to manufacturer’s 
protocol. Quality and quantity of RNA was estimated with Bioanalyzer with Nano total 
RNA Chips (Agilent, Santa Clara, CA, USA), the RIN values exceeded 7.8 for all samples 
used for microarray measurement. Total RNA was amplified, fragmented and labeled with 
biotin using the GeneChip WT Pico Reagent Kit (Affymetrix, Santa Clara, CA, USA) and 
samples were hybridized to GeneChip Mouse ST Arrays 2.0 according to the manufacturer’s 
instructions. Probeset signal intensities were background-corrected and normalized using the 
RMA algorithm. Significantly regulated genes were identified using paired-T tests (pairing 
Theurl et al. Page 16
Nat Med. Author manuscript; available in PMC 2017 January 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
by animal, limma package of R/Bioconductor) with Benjamini-Hochberg correction for 
multiple testing. Genes regulated at least 1.5 fold with p < 0.1 were considered significant. 
The microarray analysis was done with CARMAweb 1.5 software38.
Statistics
Results are expressed as Means ± SEM or ± SD as indicated. Where appropriate, the sample 
size required to reach statistical power was calculated assuming an alpha = 0.05 (P-value) 
and a beta = 0.1 (90%). Statistical tests included the Kolmogorov-Smirnov test or 
D’Agostino & Pearson omnibus normality test (depending on sample number) used to test 
for normality distribution. F-Test was used to compare variances. If variances were 
significantly different specific corrections were used as stated in detail in each figure legend. 
Calculations for statistical differences between various groups were carried out by ANOVA 
technique and Bonferroni or Dunnett correction for multiple tests. Otherwise 2-tailed 
unpaired Student’s t test was used. In case of non-normality in distribution a Mann-Whitney 
U test was used. For serial comparisons in human subjects, the 2-tailed paired Student’s t 
test was used. Calculations for statistical differences between various groups were carried 
out by Kruskal-Wallis Dunn’s Multiple Comparison Test. P < 0.05 was used to determine 
statistical significance of parametric and non parametric data. Gene expression data 
clustering (average linkage algorithm, Euclidean distance measure) and heat map 
representation were done with the Genesis software39.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Myeloid cells in the liver are the major scavengers of stressed erythrocytes
(a) Ex vivo labeling of isolated erythrocytes (Ter119+) and their identification (pkh26+) 
amongst all erythrocytes 0.01 h after i.v. injection into congenic recipients. Means ± SEM; 
[n = 5 per group]. (b) Total number of CD45+ WBC that have ingested pkh26-labeled sRBC 
16 h after delivery. Means ± SEM; [n = 5 per group, except peritoneum n = 3; *** P < 0.001 
compared to each of the other organs; Anova and Dunnett’s Multiple Comparison Test]. (c) 
Representative dot plots (1 of 3 experiments) and (d) quantification showing the effects of 
splenectomy, hepatectomy, and a combination thereof on the distribution of pkh26+ Ter119+ 
CD45− cells in the circulation 0.01 h and 16 h after sRBC delivery. sRBC (white circles) or 
young RBC (yRBC, grey circles) were injected 1 d after surgery. Means ± SEM; [n = 4 for 
the yRBC, splenectomy and sham groups; n = 3 for hepatectomy and for hepatectomy 
combined with splenectomy; *P < 0.05, ***P < 0.001 compared to young RBC (yRBC); 
Anova and Dunnett’s Multiple Comparison Test]. (e) Representative dot plots (1 of 3 
experiments) showing gating for F4/80high CD11bint KC, F4/80low CD11bhigh monocytes 
(Mo)/neutrophils (Neu) and F4/80high CD11bhigh tMΦ in the liver and F4/80high 
CD11bint/low RPM, F4/80low CD11bhigh Mo/Neu, and F4/80high CD11bhigh tMΦ in the 
spleen in steady state (0 h), 16 h, and 72 h after sRBC challenge. All cells gated as CD45+ 
Lin− (CD3, CD19, NK1.1) leukocytes in liver and spleen 16 h after ghost challenge (on the 
right). (f) Dynamics of indicated leukocyte populations in liver (left) and spleen (right) after 
sRBC challenge. Means ± SD; [n = 6 for time-point 0, n = 3 for all other time-points]. (g) 
Representative dot plots (1 of 3 experiments) showing uptake of pkh26+ sRBC in liver and 
spleen by KC, RPM, tMΦ, and Mo/Neu 16 h after delivery. (h) Cytoplasmic pkh26 staining 
in KC, RPM, and tMΦ sorted from the liver and spleen 16 h after sRBC delivery. Blue 
denotes nuclei with DAPI staining and red denotes pkh26-sRBC. (i) Dynamics of iron 
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content measured by atomic absorption spectroscopy (AAS) in sorted leukocyte populations 
in liver (left) and spleen (right) after sRBC challenge (each sample pooled from 3–6 mice). 
(j) Transmission electron microscopy of a liver section, 16 h after sRBC challenge, showing 
peri-hepatocellular leukocyte infiltrate surrounding RBC (arrows).
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Figure 2. Ly-6Chigh monocytes differentiate to FPN1+ macrophages for transient erythrocyte 
removal
(a) Representative dot plots (1 of 3 experiments) showing FPN1 expression in steady state (4 
panels on the left) in different WBC populations of the liver and spleen and 16 h after sRBC 
challenge (6 panels on the right), Means ± SEM; [n = 5 per group]. (b) Representative dot 
plot (1 of 2 experiments) overlays showing adoptively transferred GFP+ Ly-6Chigh (red) and 
Ly-6Clow (blue) monocytes differentiating in the liver and spleen at 16 h and 72 h after 
sRBC challenge. Gray dots represent endogenous populations in the overlay. An overlay of 
monocytes in the blood 0.01 h after transfer is shown on the left. (c) Parabiosis experiment 
outline and graphs showing time course of chimerism for circulating monocytes, KC, and 
RPM in steady state (control) and after sRBC challenge. Means ± SEM; [n = 4 per group 
and time point; * P < 0.05; Mann-Whitney test]). (d) Iron and immune-specific gene 
expression in sRBC-loaded and unloaded KC and liver tMΦ 16 h after sRBC challenge. 
Representative dot plots on the left show gating strategy for cell isolation. Green = low 
expression. Red = high expression. (e) Scheme and data of formal lineage tracing 
experiments involving Cx3cr1-CreERT2 females crossed with R26-tdT males. (f) Whole-
genome expression profiling in mKC and eKC [n = 3 per group]. Volcano plot depicts -log10 
Benjamini-Hochberg-corrected p-value versus log2 fold-regulation for each gene. Genes 
significantly augmented (pBenjamini-Hochberg < 0.1 and fold regulation > 1.5) in mKC and 
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eKC are highlighted in green and red, respectively. (g) Tim-4 cell surface expression in liver 
KC and monocytes in steady state (0 h) and 7 d after sRBC challenge. Representative dot 
plots (1 of 3 experiments).
Theurl et al. Page 23
Nat Med. Author manuscript; available in PMC 2017 January 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. Csf1 and Nrf2 are essential to FPN1+ macrophage generation
(a) Csf1, (b) Csf2 mRNA expression, and (c) the ratio of Csf1 to Csf2 in liver and spleen in 
steady state and 6 h after challenge with either sRBC, ghosts or PBS control. Means ± SEM; 
[n = 8 control and sRBC, n = 6 ghosts; ***P < 0.001 Kruskal-Wallis and Dunn’s Multiple 
Comparison Test comparing all groups to controls]. (d) Slc40a1 mRNA expression on 
mouse Ly-6Chigh monocytes cultured with recombinant (r) Csf1, rCsf2, and sRBC. Means ± 
SEM; [n = 3 per group; *** P < 0.001 unpaired two-tailed t-test comparing Csf1 and Csf2-
incubated monocytes for each condition]. Rps29 is the housekeeping gene. (e) SLC40A1 
mRNA expression on human CD14high CD16− monocytes cultured with rCSF1, rCSF2, and 
sRBC. Means ± SEM;; [n = 6 per group; ***P < 0.001 Anova Bonferroni’s Multiple 
Comparison test comparing Csf1 and Csf2-incubated monocytes for each condition]. (f) 
Slc40a1 mRNA expression on Ly-6Chigh monocytes cultured with rCsf1 and decreasing 
doses of rCsf2, with sRBC. Means ± SEM; [n = 5 per group, except Csf2 0.01 ng/ml group, 
n = 3; *** P < 0.001, **P < 0.01 compared to rCsf1-cultured monocytes; Anova and 
Dunnett’s Multiple Comparison Test]. (g) Slc40a1 mRNA expression on mouse Ly-6Chigh 
monocytes sorted from WT and Nrf2−/− mice and cultured with rCsf, rCsf2, and sRBC. 
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Means ± SEM, ***P ≤ 0.001 compared to rCsf1-cultured monocytes for the same strain; 
Mann Whitney U test (n = 5 per group, except Nrf2−/− Csf2 group, n = 4). (h) 
Representative dot blots (1 of 3 experiments) and (i) quantification of KC and tMΦ in liver 
of WT mice in the steady state (white bars), and 16 h after sRBC challenge in WT mice, WT 
mice treated with the c-fms tyrosine kinase inhibitor Ki20227 (Csf1 inh.) and Nrf2−/− mice 
(grey bars). Means ± SEM; [n = 3 for WT control, WT sRBC, and WT sRBC/Ki20227; n = 
4 for Nrf2−/− sRBC; ***P < 0.001 compared to sRBC-challenged WT mice; Anova 
Bonferroni’s Multiple Comparison test].
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Figure 4. The on-demand mechanism preserves homeostasis
(a) Ccl2 (left) and Ccl3 (right) mRNA levels in the liver and spleen in response to sRBC or 
PBS. Means ± SEM; [n = 6 per group; ***P < 0.001; Anova Bonferroni’s Multiple 
Comparison test]. (b) Quantification showing the effect of Ccr2 and Ccr5 antagonists (ant) 
on Ly-6Chigh monocyte and tMΦ numbers in liver, spleen, blood, and bone marrow 16 h 
after sRBC challenge. Means ± SEM; [n = 10 Ant, n = 9 (sRBC bone marrow), n = 10 
(sRBC/ant bone marrow), n = 14 all other groups (liver, spleen, blood); ****P < 0.0001, 
***P < 0.001, **P < 0.01, and * P < 0.05; Anova Bonferroni’s Multiple Comparison test]. 
(c) Quantification showing the effect of Ccr2 and Ccr5 antagonist treatment on pkh26+ 
Ter119+ CD45− cell retention, as a fraction of the entire erythrocyte pool in the circulation 
16 h after sRBC challenge. Means ± SEM; [n = 4 per group; *P < 0.05; Mann-Whitney U 
test]. (d) Effect of Ccr2 and Ccr5 antagonists (ant) on enhanced labile plasma iron (eLPI) 
levels in mice challenged with sRBC or controls. Means ± SEM; [n = 8 Ant, n = 9 sRBC, n 
= 7 sRBC/Ant; ** P < 0.001; Anova Bonferroni’s Multiple Comparison test]. (e) Effect of 
Ccr2 and Ccr5 antagonists (Ant) on hemopexin and haptoglobin mRNA levels in the livers 
of mice challenged with sRBC or controls. Means ± SEM; [n = 4 per group; * P < 0.05; 
Anova Bonferroni’s Multiple Comparison test]. (f) Effect of Ccr2 and Ccr5 antagonists 
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(Ant) on liver transaminase ALT, AST, Amylase, and blood urea nitrogen (BUN) activities 
and levels in serum 16 h after sRBC challenge. Means ± SEM; [n = 4 per group; *P < 0.05, 
**P < 0.01, and ***P < 0.001; Anova Bonferroni’s Multiple Comparison test]. (g) Prussian 
blue staining on kidneys (nephron) from the three groups listed above. Iron depositions 
appear in blue, hemosiderin appears brown.
Theurl et al. Page 27
Nat Med. Author manuscript; available in PMC 2017 January 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
